• HyperPFU™ high-fidelity DNA polymerase protocol

  2026-09-01

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate PCR amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is appropriate for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or preformed sticky ends.

• How Near-Death Stress Creates Prometastatic States

  2026-09-01

  Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending apoptotic event can become stable prometastatic cells, termed PAMEs, through ER-stress signaling, transcriptional reprogramming, and cytokine-mediated communication. The study offers a mechanistic framework for understanding how cell-death-inducing treatment may remodel a primary tumor toward dissemination and identifies experimental variables that should be monitored in cancer research.

• Ratiometric Imaging of Amyloid-β Fibrils

  2026-08-31

  The reference study introduces tris-heteroleptic ruthenium complexes that combine fluorescence and phosphorescence for internal-reference detection of amyloid-β aggregation. Complex 2 additionally supports confocal imaging, producing a stronger ratiometric response toward Aβ40 than Aβ42 and providing a practical optical framework for aggregation-focused Alzheimer’s disease research.

• Epalrestat: From Polyol Pathway to Neuroprotection

  2026-08-31

  Epalrestat is more than an aldose reductase inhibitor for diabetic neuropathy research. Emerging evidence links polyol pathway inhibition with KEAP1/Nrf2 activation, reduced oxidative stress, improved mitochondrial function, and dopaminergic neuron protection in Parkinson’s disease models. This thought-leadership guide translates those findings into practical experimental and translational strategies.

• CB-839: Assay Design for Glutamine Dependence

  2026-08-30

  CB-839, also known as Telaglenastat, enables direct investigation of GLS1-dependent glutaminolysis. This article translates recent PRMT5–splicing findings in MYCN-amplified neuroblastoma into a practical framework for metabolic assays, orthogonal validation, and preclinical cancer drug evaluation.

• Staurosporine A8192: Reliable Cell Assay Design

  2026-08-29

  This scenario-based guide explains how Staurosporine (SKU A8192) can strengthen apoptosis, viability, proliferation, and kinase-signaling workflows. It emphasizes solvent control, matrix-aware experimental design, orthogonal readouts, and practical product-selection criteria for reproducible cancer research.

• WDR54 and Metastatic HNSCC Cell Identity

  2026-08-28

  This Science Bulletin study integrates single-cell, trajectory, genetic, epigenomic, and functional evidence to define WDR54 as a regulator of cellular identity reshaping during metastatic head and neck squamous cell carcinoma. Its findings connect SCGB3A1-positive malignant epithelial cells, CXCL14-positive cancer-associated fibroblast-like states, B2M-positive terminal states, and a TGF-β-linked chromatin program that may explain metastatic plasticity.

• 5-hme-dCTP for DNA Hydroxymethylation Workflows

  2026-08-28

  Use 5-hme-dCTP to build defined 5hmC-containing controls, test polymerase incorporation, and strengthen DNA hydroxymethylation assay development. Its greatest value is as a controlled modified-nucleotide substrate that complements, rather than replaces, genome-wide mapping methods used in gene regulation and plant stress research.

• Methylprednisolone Sodium Succinate in Cell Assays

  2026-08-27

  Build reproducible inflammation, immunology, neutrophil, and tumor-cell workflows with a concentration-aware design for Methylprednisolone Sodium Succinate. The guide separates product benchmarks from pilot recommendations and shows how time-resolved controls can improve interpretation across cytokine, ROS, chemotaxis, and apoptosis assays.

• 7ACC2: Monocarboxylate Transporter 1 Inhibitor

  2026-08-27

  7ACC2 combines potent MCT1 blockade with disruption of mitochondrial pyruvate transport, making it useful for separating lactate dependence from broader metabolic stress. This practical guide shows how to deploy it in transport assays, cancer metabolism research, radiosensitization studies, and exploratory tumor–macrophage models.

• SB 431542 in Pulmonary Vascular Remodeling

  2026-08-26

  SB 431542 is an ALK5 inhibitor that helps separate TGF-β receptor signaling from upstream KIR2.1-driven events in pulmonary artery smooth muscle cells. This article translates a mechanistic study into practical assay design, interpretation, and experimental controls.

• Protease Inhibitor Cocktail for MHC-I Research

  2026-08-26

  Learn how a Protease Inhibitor Cocktail EDTA-Free can protect lysate quality when studying MHC-I antigen presentation, MCRS1 signaling, and immunotherapy response. This guide connects mechanistic cancer biology with practical, phosphorylation-compatible sample handling.

• HMGCS2, LysoPC, and Pulmonary Fibrosis

  2026-08-25

  Yang et al. identify injured alveolar type II epithelial cells as a major source of pathogenic lysophosphatidylcholine in experimental pulmonary fibrosis. Their results connect reduced epithelial HMGCS2 to defective lipid degradation, fibroblast activation, and disease progression through a PPARα-associated CPT1A/CPT2 regulatory mechanism.

• Staurosporine A8192 for Reliable Cell Assays

  2026-08-25

  This scenario-driven guide explains how Staurosporine (SKU A8192) can support apoptosis, kinase-signaling, viability, and fractional-killing experiments. It covers assay interpretation, DMSO handling, imaging-based validation, and practical vendor-selection criteria for reproducible cancer research workflows.

• Candida auris Antifungal Pipeline: Systematic Review

  2026-08-24

  Treviño-Rangel and colleagues systematically evaluated emerging antifungal candidates against multidrug-resistant Candida auris, integrating susceptibility data with evidence from neutropenic animal models. The review highlights manogepix/fosmanogepix, ibrexafungerp, and rezafungin while showing why tetrazoles and other first-in-class agents require careful interpretation across assay systems and stages of development.

8530 records 1/569 page Next 12345 下5页 Last page